Recipient Organization
TUFTS UNIVERSITY
200 WESTBORO ROAD
N. GRAFTON,MA 01536
Performing Department
Infectious Disease and Global Health
Non Technical Summary
Clostridium difficile is a pathogen causing pseudomembranous colitis, which accounts for a quarter of all cases of antibiotic-associated diarrhea. The incidence of C. difficile infection (CDI) has increased significantly in both North America and Europe, causing lengthy hospitalization, substantial morbidity and mortality.
Animal Health Component
(N/A)
Research Effort Categories
Basic
(N/A)
Applied
(N/A)
Developmental
(N/A)
Goals / Objectives
The purpose of this study is to conduct in vitro testing of the drug Diosmectite in C. difficile assays. The specific aims are to: 1) Determine the toxin-binding activities. 2) Determine the binding affinity. 3) Determine the neutralizing / blocking effects. 4) Determine the effects on antibiotics.
Project Methods
Ad 1): use culture supernatants from laboratory and epidemic strains. ELISA to measure toxins. Neutralizing assay to measure biological activities (turnaround time 8-11 days). Ad 2): use purified TcdA and TcdB (turnaround time 3-5 days). Ad 3): on polarized monolayers using transwell system (turnaround time 21-25 days). Ad 4: metronidazole and vancomycin (turnaround time 8-11 days).